News
Media
PodcastsCase Based Peer PerspectivesInsightsInvestigator PerspectivesMedical World NewsPeer ExchangePeers & PerspectivesVideos
Conferences
Conference CoverageConference Listing
Publications
Contemporary OB/GYN® JournalDigital Supplements
More
CME/CE
Resources
Physician Fact SheetsInteractive ToolsSponsored MediaSponsored ResourcesSupplements and Featured Publications
About
Partnerships

Subscribe

  • News
  • Media
  • Conferences
  • Publications
  • CME/CE
  • Resources
  • Subscribe
  • About
  • Partnerships
  • Breast Health
  • COVID-19
  • Cervical Health
  • Contraception
  • Curbside Consults
  • Dermatology
  • Drug Pipeline News
  • Endometriosis
  • Genetic Testing
  • Gynecology
    • Gynecologic Oncology
  • Imaging
    • Fetal Imaging
    • Abnormal Obstetrical Ultrasound
    • MRI
    • Ultrasound
    • Women's Imaging
    • Breast Imaging
    • Women's Ultrasound
  • Infertility
  • LARC
  • Legally Speaking
  • Life Transitions
  • Malpractice
  • Menopause
  • Mental Health
  • Noninvasive Prenatal Testing
  • Obstetrics
  • Opinion
  • Osteoporosis
  • Pediatrics
  • Practice Management
  • Pregnancy and Birth
  • Sexual Health
  • Sexually Transmitted Infections
  • Surgery
  • Technology
  • Urology
  • Uterine Fibroids
  • Vulvovaginal Disease
  • Well Woman
Advertisement

Barbara A. McGuirk, MD

Advertisement

Articles by Barbara A. McGuirk, MD

Fertility Care and Severe Polycystic Ovarian Syndrome (PCOS)

ByRonald F. Feinberg, MD, PhD,Barbara A. McGuirk, MD,Joy Biancosino, RN,Ronald F. Feinberg, MD, PhD,Barbara A. McGuirk, MD,Joy Biancosino, RN,Ronald F. Feinberg, MD, PhD,Barbara A. McGuirk, MD,Joy Biancosino, RN
October 8th 2011

In women with severe clomiphene-resistant PCOS, we proposed thatthe insulin-lowering agent troglitazone (Rezulin®) could have a positive impact on the ovarian microenvironment by supporting normal follicular growth, ovulation, and successful pregnancy.

Advertisement

Latest Updated Articles

  • Fertility Care and Severe Polycystic Ovarian Syndrome (PCOS)
    Fertility Care and Severe Polycystic Ovarian Syndrome (PCOS)

    Published: October 8th 2011 | Updated:



Advertisement
Advertisement

Trending on Contemporary OB/GYN

1

FDA clears FemVue Controlled for in-office tubal assessment

2

Michelle Manzo, MPH, CMPP, discusses epilepsy challenges in motherhood

3

GSK, Spero Therapeutics resubmits NDA for tebipenem HBr as oral option for complicated urinary tract infections

4

Multidisciplinary initiative boosts iron deficiency screening in pregnancy

5

FDA approves expanded use of flibanserin for hypoactive sexual desire disorder in women

  • Advertise
  • Contact Us
  • Job Board
  • Terms of Use
  • Privacy Policy
  • Do Not Sell My Personal Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us